Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

(RTTNews) - Guardant Health Inc. (GH) and Hikma Pharmaceuticals have entered into an agreement to collaborate on the promotion of Guardant Health's range of liquid and tissue biopsy tests. The focus will be on cancer screening, recurrence monitoring, and tumor mutation profiling, https://www.nasdaq.com/articles/guardant-health-hikma-to-offer-cancer-screening-genomic-profiling-tests-in-middle-east